Parthenolide
As of the edition of 20 October 2026, Parthenolide is a small molecule: marketed, first approved in 2010 (CH).
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 2020
- Kind
- Small molecule
- Brand name
- True Test
- First approved
- 29 September 2010 (CH)
- Approvals on record
- 2 in 2 regions
- Holder of the most recent approval
- SMARTPRACTICE DENMARK (DANEMARK); 2 holders in all
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Who has held its approvals
| Company | Role | Years |
|---|---|---|
| Stallergenes | Applicant | 2010 to now |